Monday, June 19, 2023
Gene Bio Medical, also known as Gene Biotechnology Enterprises Ltd., is thrilled to announce a strategic partnership with the Canadian Hub for Health Intelligence & Innovation in Infectious Diseases (HI³). This collaboration is a significant part of the "Pandemic preparedness engaging primary care and emergency departments (PREPARED)" initiative.
Led by Dr. Andrew Pinto, Founder and Director of the Upstream Lab and Associate Professor at the University of Toronto, the PREPARED project aims to engage primary care and emergency departments across six Canadian provinces. It focuses on four key objectives: integrating point-of-care tests, improving surveillance, linking patients to trials, and accelerating diagnostic creation. These efforts are crucial in enhancing pandemic preparedness.
HI³ is a collaborative coalition consisting of academic institutions, hospitals, research networks, industry partners, government entities, not-for-profit organizations, and community stakeholders, including the University of Toronto. As one of the five hubs evaluating R&D projects for the Canada Biomedical Research Fund (CBRF) and Biosciences Research Infrastructure Fund (BRIF), HI³'s mission is to strengthen Canada's biomanufacturing capacity and ensure a coordinated response to future pandemics and infectious health threats.
Gene Bio Medical has been invited by Dr. Pinto to contribute to the commercialization and manufacturing aspects of the PREPARED project. Their partnership highlights Gene Bio Medical's expertise in these areas and their commitment to advancing global health solutions. By accelerating the development and deployment of innovative diagnostic solutions, Gene Bio Medical will play a crucial role in achieving the project's objectives.
This partnership signifies Gene Bio Medical's third collaboration within the CBRF/BRIF program, further establishing their reputation as a trusted partner for commercialization and manufacturing among leading R&D organizations.
CEO Jessica Hu expressed her pride in the collaboration, stating, "We are proud to collaborate with HI³ and contribute to the PREPARED project. Our continued involvement in initiatives under the CBRF/BRIF program reflects our dedication to advancing global health solutions."
